Mobile System Captures and Manages ECG Data
By HospiMedica International staff writers Posted on 24 Jun 2015 |
Image: The InvisionHeart 12-lead ECG device (Photo courtesy of InvisionHeart).
A novel cloud-based healthcare IT platform enables physicians, nurses, and care providers to capture, review, and annotate patient 12-lead electrocardiogram (ECG) tracings.
The InvisionHeart ECG System is a mobile, cost-effective, technological solution for capturing and managing 12-lead ECGs, including the ability to read and visually compare, confirm, report, and store diagnostic quality readings. A proprietary high resolution 12-lead ECG device with an intuitive capture system is first used to record the ECG. The data is then transmitted to InvisionConnect, a secure cloud-based platform that allows a network of physicians, nurses, and technicians, to securely access and interpret patient the ECG readings.
Credentialed users can access ECGs from any web-enabled device, and additional cloud-based tools, such as messaging and notifications, help in the timely evaluation of patient ECGs. A web-based application with enhanced diagnostic tools assists in the review and formal diagnosis of patient ECGs, and integrates with electronic medical record systems (EMRs). The InvisionHeart ECG System is a product of InvisionHeart (Nashville, TN, USA), and has been approved by the US Food and Drug Administration (FDA).
“Initial interest has been strong from a broad array of potential users, especially those challenged to find a high-quality, low-cost solution that is secure and fully electronic,” said Melanie Varin, executive vice president of sales and marketing at InvisionHeart. “In addition to hospitals, we’ve detected genuine enthusiasm from the rapidly growing markets for home health and ambulatory care as well as other specialty markets.”
“This is a significant milestone in the development of our technology and, more importantly, a breakthrough in our ability to serve patients where ECGs have been traditionally unavailable,” said Josh Nickols, PhD, President and CEO of InvisionHeart. “Earlier diagnosis of cardiac issues via improved access will benefit patients, whether in the hospital setting or at home.”
In a conventional 12-lead ECG, electrodes are placed on the patient's limbs and on the surface of the chest. The overall magnitude of the heart's electrical potential is then measured from twelve different angles and is recorded over a period of time (usually 10 seconds). The heart's electrical depolarization is thus captured at each moment throughout the cardiac cycle, displayed as a graph representing of voltage versus time, i.e., the ECG.
Related Links:
InvisionHeart
The InvisionHeart ECG System is a mobile, cost-effective, technological solution for capturing and managing 12-lead ECGs, including the ability to read and visually compare, confirm, report, and store diagnostic quality readings. A proprietary high resolution 12-lead ECG device with an intuitive capture system is first used to record the ECG. The data is then transmitted to InvisionConnect, a secure cloud-based platform that allows a network of physicians, nurses, and technicians, to securely access and interpret patient the ECG readings.
Credentialed users can access ECGs from any web-enabled device, and additional cloud-based tools, such as messaging and notifications, help in the timely evaluation of patient ECGs. A web-based application with enhanced diagnostic tools assists in the review and formal diagnosis of patient ECGs, and integrates with electronic medical record systems (EMRs). The InvisionHeart ECG System is a product of InvisionHeart (Nashville, TN, USA), and has been approved by the US Food and Drug Administration (FDA).
“Initial interest has been strong from a broad array of potential users, especially those challenged to find a high-quality, low-cost solution that is secure and fully electronic,” said Melanie Varin, executive vice president of sales and marketing at InvisionHeart. “In addition to hospitals, we’ve detected genuine enthusiasm from the rapidly growing markets for home health and ambulatory care as well as other specialty markets.”
“This is a significant milestone in the development of our technology and, more importantly, a breakthrough in our ability to serve patients where ECGs have been traditionally unavailable,” said Josh Nickols, PhD, President and CEO of InvisionHeart. “Earlier diagnosis of cardiac issues via improved access will benefit patients, whether in the hospital setting or at home.”
In a conventional 12-lead ECG, electrodes are placed on the patient's limbs and on the surface of the chest. The overall magnitude of the heart's electrical potential is then measured from twelve different angles and is recorded over a period of time (usually 10 seconds). The heart's electrical depolarization is thus captured at each moment throughout the cardiac cycle, displayed as a graph representing of voltage versus time, i.e., the ECG.
Related Links:
InvisionHeart
Latest Health IT News
- Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
- Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
- AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
- AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
- First Fully Autonomous Generative AI Personalized Medical Authorizations System Reduces Care Delay
- Electronic Health Records May Be Key to Improving Patient Care, Study Finds
- AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease
- First-Ever AI Test for Early Diagnosis of Alzheimer’s to Be Expanded to Diagnosis of Parkinson’s Disease
- New Self-Learning AI-Based Algorithm Reads Electrocardiograms to Spot Unseen Signs of Heart Failure
- Autonomous Robot Performs COVID-19 Nasal Swab Tests
- Statistical Tool Predicts COVID-19 Peaks Worldwide
- Wireless-Controlled Soft Neural Implant Stimulates Brain Cells
- Tiny Polymer Stent Could Treat Pediatric Urethral Strictures
- Human Torso Simulator Helps Design Brace Innovations
- 3D Bioprinting Rebuilds the Human Heart